Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

NCT00084773 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: fluorouracil
PROCEDURE: neoadjuvant therapy
RADIATION: radiation therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]